These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 16916559)

  • 1. Microsatellite alterations in head and neck squamous cell carcinoma and relation to expression of pimonidazole, CA IX and GLUT-1.
    De Schutter H; Barbé B; Spaepen M; Begg AC; Balm A; Gregoire V; Haustermans K; Mahy P; Vander Poorten V; Nuyts S
    Radiother Oncol; 2006 Aug; 80(2):143-50. PubMed ID: 16916559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pimonidazole binding and tumor vascularity predict for treatment outcome in head and neck cancer.
    Kaanders JH; Wijffels KI; Marres HA; Ljungkvist AS; Pop LA; van den Hoogen FJ; de Wilde PC; Bussink J; Raleigh JA; van der Kogel AJ
    Cancer Res; 2002 Dec; 62(23):7066-74. PubMed ID: 12460928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prognostic value of the hypoxia markers CA IX and GLUT 1 and the cytokines VEGF and IL 6 in head and neck squamous cell carcinoma treated by radiotherapy +/- chemotherapy.
    De Schutter H; Landuyt W; Verbeken E; Goethals L; Hermans R; Nuyts S
    BMC Cancer; 2005 Apr; 5():42. PubMed ID: 15847702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prognostic value of endogenous hypoxia-related markers for head and neck squamous cell carcinomas treated with ARCON.
    Jonathan RA; Wijffels KI; Peeters W; de Wilde PC; Marres HA; Merkx MA; Oosterwijk E; van der Kogel AJ; Kaanders JH
    Radiother Oncol; 2006 Jun; 79(3):288-97. PubMed ID: 16730088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypoxia in larynx carcinomas assessed by pimonidazole binding and the value of CA-IX and vascularity as surrogate markers of hypoxia.
    Hoogsteen IJ; Lok J; Marres HA; Takes RP; Rijken PF; van der Kogel AJ; Kaanders JH
    Eur J Cancer; 2009 Nov; 45(16):2906-14. PubMed ID: 19699082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carbonic anhydrase IX, an endogenous hypoxia marker, expression in head and neck squamous cell carcinoma and its relationship to hypoxia, necrosis, and microvessel density.
    Beasley NJ; Wykoff CC; Watson PH; Leek R; Turley H; Gatter K; Pastorek J; Cox GJ; Ratcliffe P; Harris AL
    Cancer Res; 2001 Jul; 61(13):5262-7. PubMed ID: 11431368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of prognostic and predictive value of CA IX in radiotherapy of squamous cell carcinoma of the head and neck with known modifiable hypoxia: an evaluation of the DAHANCA 5 study.
    Eriksen JG; Overgaard J;
    Radiother Oncol; 2007 Jun; 83(3):383-8. PubMed ID: 17543403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microsatellite instability and loss of heterozygosity in squamous cell carcinoma of the head and neck.
    Koy S; Plaschke J; Luksch H; Friedrich K; Kuhlisch E; Eckelt U; Martinez R
    Head Neck; 2008 Aug; 30(8):1105-13. PubMed ID: 18615731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIF-1α and CA-IX as predictors of locoregional control for determining the optimal treatment modality for early-stage laryngeal carcinoma.
    Kwon OJ; Park JJ; Ko GH; Seo JH; Jeong BK; Kang KM; Woo SH; Kim JP; Hwa JS; Carey TE
    Head Neck; 2015 Apr; 37(4):505-10. PubMed ID: 24677746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relation of erythropoietin and erythropoietin receptor expression to hypoxia and anemia in head and neck squamous cell carcinoma.
    Winter SC; Shah KA; Campo L; Turley H; Leek R; Corbridge RJ; Cox GJ; Harris AL
    Clin Cancer Res; 2005 Nov; 11(21):7614-20. PubMed ID: 16278379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical detection of osteopontin in advanced head-and-neck cancer: prognostic role and correlation with oxygen electrode measurements, hypoxia-inducible-factor-1alpha-related markers, and hemoglobin levels.
    Bache M; Reddemann R; Said HM; Holzhausen HJ; Taubert H; Becker A; Kuhnt T; Hänsgen G; Dunst J; Vordermark D
    Int J Radiat Oncol Biol Phys; 2006 Dec; 66(5):1481-7. PubMed ID: 17056190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endogenous markers of two separate hypoxia response pathways (hypoxia inducible factor 2 alpha and carbonic anhydrase 9) are associated with radiotherapy failure in head and neck cancer patients recruited in the CHART randomized trial.
    Koukourakis MI; Bentzen SM; Giatromanolaki A; Wilson GD; Daley FM; Saunders MI; Dische S; Sivridis E; Harris AL
    J Clin Oncol; 2006 Feb; 24(5):727-35. PubMed ID: 16418497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GLUT-1 and CAIX as intrinsic markers of hypoxia in carcinoma of the cervix: relationship to pimonidazole binding.
    Airley RE; Loncaster J; Raleigh JA; Harris AL; Davidson SE; Hunter RD; West CM; Stratford IJ
    Int J Cancer; 2003 Mar; 104(1):85-91. PubMed ID: 12532423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The clinical relevance of microsatellite alterations in head and neck squamous cell carcinoma: a critical review.
    De Schutter H; Spaepen M; Mc Bride WH; Nuyts S
    Eur J Hum Genet; 2007 Jul; 15(7):734-41. PubMed ID: 17473833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of tissue necrosis, hypoxia-related markers and correlation with HPV status in head and neck cancer patients treated with bio- or chemo-radiotherapy.
    Ou D; Garberis I; Adam J; Blanchard P; Nguyen F; Levy A; Casiraghi O; Gorphe P; Breuskin I; Janot F; Temam S; Scoazec JY; Deutsch E; Tao Y
    Radiother Oncol; 2018 Jan; 126(1):116-124. PubMed ID: 29079308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression and prognostic significance of a panel of tissue hypoxia markers in head-and-neck squamous cell carcinomas.
    Le QT; Kong C; Lavori PW; O'byrne K; Erler JT; Huang X; Chen Y; Cao H; Tibshirani R; Denko N; Giaccia AJ; Koong AC
    Int J Radiat Oncol Biol Phys; 2007 Sep; 69(1):167-75. PubMed ID: 17707270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sequential loss of heterozygosity at microsatellite motifs in preinvasive and invasive head and neck squamous carcinoma.
    el-Naggar AK; Hurr K; Batsakis JG; Luna MA; Goepfert H; Huff V
    Cancer Res; 1995 Jun; 55(12):2656-9. PubMed ID: 7780981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypoxia, metabolism, and growth factor signaling in head and neck squamous cell carcinoma: correlation between primary and xenograft tumors.
    Stegeman H; Rademakers SE; Span PN; Takes RP; van der Kogel AJ; Kaanders JH; Bussink J
    Head Neck; 2014 Sep; 36(9):1288-95. PubMed ID: 24668936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fractional allele loss indicates distinct genetic populations in the development of squamous cell carcinoma of the head and neck (SCCHN).
    Nunn J; Scholes AG; Liloglou T; Nagini S; Jones AS; Vaughan ED; Gosney JR; Rogers S; Fear S; Field JK
    Carcinogenesis; 1999 Dec; 20(12):2219-28. PubMed ID: 10590212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low microsatellite instability and high loss of heterozygosity rates indicate dominant role of the suppressor pathway in squamous cell carcinoma of head and neck and loss of heterozygosity of 11q14.3 correlates with tumor grade.
    Glavac D; Volavsek M; Potocnik U; Ravnik-Glavac M; Gale N
    Cancer Genet Cytogenet; 2003 Oct; 146(1):27-32. PubMed ID: 14499693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.